The new guide explores how brands can tap into the $11B gaming ad opportunity with immersive formats, smart targeting, and player-first experiencesAUSTIN, Texas, June 12, 2025 /PRNewswire/ -- Orange 142, a division of Direct Digital Holdings (NASDAQ: DRCT) and a leader in digital marketing for mid-market brands, today released a new best practices guide focused on in-game advertising. The guide is designed to help marketers unlock the full potential of gaming as a marketing channel, connecting with audience ...

AUSTIN, Texas, June 12, 2025 /PRNewswire/ -- eHealth, Inc. (Nasdaq: EHTH) (eHealth.com), a leading online private health insurance marketplace, has been named as one of this year's Best Workplaces in Texas by Great Place To Work and Fortune magazine. eHealth is proud to be named to this prestigious list, coming in at No. 25. To be selected, eHealth surpassed rigorous benchmarks and has established itself as one of the best workplaces in Texas. To determine the Fortune Best Workplaces in Texas™ List, Great P ...

NEW YORK, June 12, 2025 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against Red Cat Holdings, Inc. ("Red Cat" or the "Company") (NASDAQ: RCAT) and certain officers.  The class action, filed in the United States District Court for the District of New Jersey, and docketed under 25-cv-05427, is on behalf of a class consisting of all persons and entities other than Defendants that purchased or otherwise acquired Red Cat securities between March 18, 2022 and January 15, 202 ...

GALWAY, Ireland, June 12, 2025 /PRNewswire/ -- Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced MiniMed as the name for the planned New Diabetes Company following the intended separation. The name honors the company's roots, reflecting its original name prior to its acquisition by Medtronic in 2001, and a deep 40-year history of being at the forefront of transforming diabetes care around the world.   Key Payton with his wife Cheri Payton "Our journey began in 1983, w ...

NEW YORK, June 12, 2025 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against PepGen Inc. ("PepGen" or the "Company") (NASDAQ: PEPG) and certain officers.  The class action, filed in the United States District Court for the Eastern District of New York, and docketed under 25-cv-03221, is on behalf of a class consisting of all persons and entities other than Defendants that purchased or otherwise acquired PepGen securities between March 7, 2024 and March 3, 2025, both dat ...

Funds and technical support will help 2025 winner bring seasonal bakery to DetroitDETROIT, June 12, 2025 /PRNewswire/ -- The winning small business of the 2025 Comerica Hatch Detroit Contest by TechTown has been announced! Walter Pat's Bakery Cafe is the winner of the 13th annual Comerica Hatch Detroit Contest, taking home the $100,000 grand prize from Comerica Bank to open the brick-and-mortar business of their dreams in Detroit, Hamtramck or Highland Park, as well as a business support package from TechTo ...

Visit booth #631 for product demos, expert insight, networking opportunities, and more TINTON FALLS, N.J., June 12, 2025 /PRNewswire/ -- Commvault, a leading provider of cyber resilience and data protection solutions for the hybrid cloud, is excited to announce its showcase at AWS re:Inforce, running June 16-18 in Philadelphia.Every year, AWS re:Inforce draws thousands of security professionals interested in learning how to enhance their organization's cloud security posture. Attendees range from CISOs and ...

Core Viewpoint - Citius Pharmaceuticals Inc. has successfully closed a registered direct offering, raising approximately $6 million, with potential additional proceeds of up to $9.8 million from short-term warrants [1][3]. Group 1: Offering Details - The offering consisted of 4,920,000 shares of common stock priced at $1.22 per share, along with short-term warrants to purchase an additional 9,840,000 shares [1][3]. - The short-term warrants have an exercise price of $1.00 per share, are immediately exercisable, and will expire 24 months from the initial exercise date [1][3]. Group 2: Use of Proceeds - The net proceeds from the offering are intended to support the commercial launch of LYMPHIR™, including milestone and regulatory payments, as well as general corporate purposes [3]. Group 3: Company Background - Citius Pharmaceuticals is focused on developing first-in-class critical care products, with LYMPHIR approved by the FDA for treating cutaneous T-cell lymphoma [6]. - The company also has a late-stage pipeline that includes Mino-Lok®, an antibiotic lock solution, and CITI-002 (Halo-Lido), a topical formulation for hemorrhoid relief [6].

BMW Motorrad brings Ituran's advanced telematics technology to motorcyclists in Brazil, significantly enhancing Ituran's total addressable marketAZOUR, Israel, June 12, 2025 /PRNewswire/ -- Ituran Location and Control Ltd. (NASDAQ: ITRN), a global leader in vehicle telematics, through its Brazilian subsidiary, and BMW Motorrad Brasil, a leader in premium motorcycle sales in Brazil, have launched a strategic partnership to offer telematics services to BMW's customers, offering rider safety, security, and con ...

Peer Reviewed Clinical Study for H3.1 Biomarker Published in Critical Care HENDERSON, Nev., June 12, 2025 /PRNewswire/ -- VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition"), a multi-national epigenetics company, today announced the publication of a new clinical manuscript suggesting that the Nu.Q® H3.1 biomarker has the potential to inform clinical care in critically-ill Intensive Care Unit (ICU) patients in the assessment of sepsis, organ failure and subphenotypes.Dr. Andrew Retter, Chief Medical Office ...